Sevim Bavbek

5.3k total citations · 1 hit paper
130 papers, 2.6k citations indexed

About

Sevim Bavbek is a scholar working on Physiology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sevim Bavbek has authored 130 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Physiology, 57 papers in Pharmacology and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sevim Bavbek's work include Asthma and respiratory diseases (69 papers), Drug-Induced Adverse Reactions (56 papers) and Respiratory and Cough-Related Research (30 papers). Sevim Bavbek is often cited by papers focused on Asthma and respiratory diseases (69 papers), Drug-Induced Adverse Reactions (56 papers) and Respiratory and Cough-Related Research (30 papers). Sevim Bavbek collaborates with scholars based in Türkiye, United States and Italy. Sevim Bavbek's co-authors include Zeynep Mısırlıgil, Dilşad Mungan, Gülfem Çelík, Ömür Aydın, Adile Berna Dursun, Yavuz Selim Demirel, Marı́a José Torres, Knut Brockow, Antonino Romano and Ewa Niżankowska‐Mogilnicka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Allergy and Clinical Immunology and Allergy.

In The Last Decade

Sevim Bavbek

118 papers receiving 2.5k citations

Hit Papers

Classification and practical approach to the diagnosis an... 2013 2026 2017 2021 2013 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sevim Bavbek Türkiye 26 1.4k 1.1k 755 641 530 130 2.6k
Elina Jerschow United States 16 532 0.4× 463 0.4× 741 1.0× 133 0.2× 292 0.6× 70 1.5k
David A. Mathison United States 22 838 0.6× 1.9k 1.6× 639 0.8× 287 0.4× 153 0.3× 45 3.1k
Joo‐Hee Kim South Korea 22 185 0.1× 512 0.4× 321 0.4× 220 0.3× 196 0.4× 189 1.9k
Susan A. Rudders United States 19 319 0.2× 390 0.3× 896 1.2× 109 0.2× 186 0.4× 36 1.3k
Terufumi Shimoda Japan 23 126 0.1× 891 0.8× 244 0.3× 150 0.2× 66 0.1× 96 1.6k
Kenneth P. Mathews United States 25 136 0.1× 724 0.6× 611 0.8× 314 0.5× 210 0.4× 67 1.7k
Camille Taillé France 29 102 0.1× 1.4k 1.2× 291 0.4× 186 0.3× 47 0.1× 162 3.1k
Adeline Gallini France 20 87 0.1× 168 0.1× 122 0.2× 143 0.2× 540 1.0× 62 1.6k
Claire Le Jeunne France 24 111 0.1× 250 0.2× 29 0.0× 276 0.4× 44 0.1× 122 1.5k
Juan Carlos Cardet United States 18 101 0.1× 587 0.5× 128 0.2× 77 0.1× 27 0.1× 43 897

Countries citing papers authored by Sevim Bavbek

Since Specialization
Citations

This map shows the geographic impact of Sevim Bavbek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sevim Bavbek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sevim Bavbek more than expected).

Fields of papers citing papers by Sevim Bavbek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sevim Bavbek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sevim Bavbek. The network helps show where Sevim Bavbek may publish in the future.

Co-authorship network of co-authors of Sevim Bavbek

This figure shows the co-authorship network connecting the top 25 collaborators of Sevim Bavbek. A scholar is included among the top collaborators of Sevim Bavbek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sevim Bavbek. Sevim Bavbek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Akın, Begüm Görgülü, et al.. (2024). Retrospective analysis of rapid drug desensitization with biologic agents: A single center experience. Clinical and Translational Allergy. 14(10). e12397–e12397. 3 indexed citations
3.
Göksel, Özlem, et al.. (2024). Hypersensitivity Reactions to Taxanes: A Multicenter Study for Outcomes and Safety of Rapid Drug Desensitization. Allergy Asthma and Immunology Research. 16(2). 142–142. 6 indexed citations
4.
Al‐Lehebi, Riyad, Mona Al‐Ahmad, Venkata Nagarjuna Maturu, et al.. (2024). Real-World Effectiveness of Mepolizumab in Severe Asthma: Results from the Multi-country, Self-controlled Nucala Effectiveness Study (NEST). Advances in Therapy. 41(11). 4008–4031. 6 indexed citations
5.
Özdemir, Seçil Kepil, Zeynep Çelebi Sözener, Gül Karakaya, et al.. (2023). Biologics for the treatment of severe asthma: Current status report 2023. Tuberkuloz ve Toraks. 71(2). 176–187. 3 indexed citations
6.
Bavbek, Sevim, Seçil Kepil Özdemir, Patrizia Bonadonna, et al.. (2023). Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper. Allergy. 79(3). 552–564. 6 indexed citations
7.
Çerçi, Pamir, Suna Büyüköztürk, Aslı Gelincik, et al.. (2023). Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs in adults. Allergologia et Immunopathologia. 51(5). 84–92. 4 indexed citations
8.
Sin, Betül Ayşe, et al.. (2023). Comparison of two diagnostic criteria in the diagnosis of anaphylaxis in a tertiary adult allergy clinic. World Allergy Organization Journal. 16(3). 100761–100761. 4 indexed citations
9.
Bavbek, Sevim, et al.. (2022). Eosinophilic granulomatosis with polyangitis: A new target for biologicals. Tuberkuloz ve Toraks. 70(1). 93–101. 7 indexed citations
10.
Aydın, Ömür, et al.. (2022). Can dose reduction be made in patients with allergic bronchopulmonary aspergillosis receiving high-dose omalizumab treatment?. European Annals of Allergy and Clinical Immunology. 56(1). 26–26. 6 indexed citations
11.
Gemicioğlu, Bilun, Arzu Didem Yalçın, Yavuz Havlucu, et al.. (2021). Country-based report: the safety of omalizumab treatment in pregnant patients with asthma. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(5). 2516–2523. 5 indexed citations
12.
Öztürk, Betül Özdel, Ömür Aydın, Yavuz Selim Demirel, et al.. (2021). Coincidence of pollen season and coronavirus disease 2019 pandemic: less time outdoors - lesser allergy symptoms in 2020. Asia Pacific Allergy. 11(2). e16–e16. 6 indexed citations
13.
Torres, Marı́a José, Axel Trautmann, Ingrid Böhm, et al.. (2020). Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity. Allergy. 76(5). 1325–1339. 84 indexed citations
14.
Barbaud, A., Lene H. Garvey, Sergio Testi, et al.. (2020). Intradermal Tests With Drugs: An Approach to Standardization. Frontiers in Medicine. 7. 156–156. 41 indexed citations
15.
Öztürk, Ayse, Ayşe Baççıoğlu, Özge Soyer, et al.. (2020). Change in Allergy Practice during the COVID-19 Pandemic. International Archives of Allergy and Immunology. 182(1). 49–52. 19 indexed citations
17.
Bakırtaş, Arzu, et al.. (2017). Physicians' preference for controller medication in mild persistent asthma. Respiratory Medicine. 131. 236–240. 3 indexed citations
18.
Çelík, Gülfem, Dilşad Mungan, Faruk Özer, et al.. (2002). Clinical Features and Atopy Profile in Turkish Subjects with Analgesic Intolerance. Journal of Asthma. 39(2). 101–106. 9 indexed citations
19.
Bavbek, Sevim. (2000). Astım Epidemiyolojisi ve Risk Faktörleri. 2(2). 57–66. 1 indexed citations
20.
Bavbek, Sevim, et al.. (1997). Endoscopic scoring system in patients with allergic rhinitis.. PubMed. 7(3). 175–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026